Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx") announces that its investee
company Agrisoma Biosciences Inc. ("Agrisoma") has been awarded the Gold Leaf
Award as "Company of the Year", by BIOTECanada for biotechnology excellence in
Canada.


BIOTECanada is a national industry association reflecting the diverse nature of
Canada's health, industrial and agricultural biotechnology sectors. In addition
to providing significant health benefits for Canadians, the biotechnology
industry has quickly become an essential part of the transformation of many
traditional cornerstones of the Canadian economy.


The Gold Leaf Awards are nominated and judged by biotechnology industry leaders,
and the awards honour companies that have made significant contributions to the
growth of Canada's biotech sector.


"Agrisoma's innovation is a fantastic demonstration of how biotechnology helps
to provide the solutions needed to address the pressing challenges facing our
society and environment. The company has offered an opportunity for farmers to
produce a dedicated energy crop using land considered marginal, without
impacting food production," commented Andrew Casey, President and CEO of
BIOTECanada. "The vision and dedication of Agrisoma offers inspiration and
promise for the economy and society more broadly. Using the tools of
biotechnology to rapidly enhance performance and enhance sustainability only
adds to the importance of agriculture in meeting the social, environmental and
economic challenges associated with rapid global population growth."


Don Konantz, President and CEO of Calyx stated, "Agrisoma's next generation
agricultural products can provide a sustainable solution for renewable energy.
Carinata is the first non-food crop that produces oil uniquely suited for "drop
in" feedstock for biojet and biodiesel fuel production and Carinata was used to
fuel the world's first 100% renewable biojet fuel flight here in Canada. This
Gold Leaf Award recognizes these accomplishments."


The Gold Leaf Award will be presented during a ceremony at the BIO International
Convention in San Diego, California at the Canada Place Pavilion on Tuesday June
24 at 4pm.


About Calyx 

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
which is developing early stage agriculture ventures. Calyx brings its depth of
experience, capital and other capacity, including its proprietary intellectual
property, to enhance plant yields. In addition to Calyx's shareholding in
Agrisoma Biosciences Inc., a company which is producing a non-food energy
feedstock crop for bioenergy, Calyx is pursuing agri-pharmaceutical
opportunities in the MMPR (Marihuana for Medical Purposes Regulations) and the
agri-tech space. The medical marihuana industry is in its infancy and is an
emerging multibillion-dollar opportunity undergoing significant regulatory and
legal reform that offers strong growth opportunities to early participants. For
further information about Calyx, please visit www.calyxbio.com.


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control. 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect.


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
Don Konantz
President & CEO
604-649-5961
dkonantz@calyxbio.com
www.calyxbio.com
Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Calyx Ventures Charts.
Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Calyx Ventures Charts.